MedPath

NYU LANGONE HEALTH

NYU LANGONE HEALTH logo
🇺🇸United States
Ownership
Private
Established
1841-01-01
Employees
10K
Market Cap
-
Website
http://www.nyulangone.org

Use of Echocardiography in the Evaluation of Chest Pain in the Emergency Department

Withdrawn
Conditions
Chest Pain
Interventions
Other: Echocardiography with strain analysis
First Posted Date
2010-05-18
Last Posted Date
2017-11-13
Lead Sponsor
NYU Langone Health
Registration Number
NCT01125072
Locations
🇺🇸

NYU School of Medicine, Langone Medical Center, New York, New York, United States

Research Study on Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy (CADASIL)

Completed
Conditions
CADASIL
First Posted Date
2010-05-03
Last Posted Date
2013-01-21
Lead Sponsor
NYU Langone Health
Target Recruit Count
100
Registration Number
NCT01114815
Locations
🇺🇸

NYU School of Medicine, New York, New York, United States

Temodar (Temozolomide), Bevacizumab, Lithium and Radiation for High Grade Glioma

Phase 2
Terminated
Conditions
Brain Cancer
Interventions
First Posted Date
2010-04-16
Last Posted Date
2016-08-04
Lead Sponsor
NYU Langone Health
Target Recruit Count
28
Registration Number
NCT01105702
Locations
🇺🇸

New York University Clinical Cancer Center, New York, New York, United States

🇺🇸

Overlook Hospital, Summit, New Jersey, United States

The Role of Cytokines in Apparently Normal Pregnancies

Withdrawn
Conditions
Pregnancy
First Posted Date
2010-04-02
Last Posted Date
2019-05-21
Lead Sponsor
NYU Langone Health
Registration Number
NCT01098214

Exhaled Nitric Oxide Levels in Infants and Young Children Infected With RSV or Other Viral Infections

Withdrawn
Conditions
Bronchiolitis
Nitric Oxide
Infection
First Posted Date
2010-04-02
Last Posted Date
2020-03-16
Lead Sponsor
NYU Langone Health
Registration Number
NCT01098227
Locations
🇺🇸

Winthrop University Hospital, Mineola, New York, United States

Community-based Approaches to Treating Hypertension and Colon Cancer Prevention

Not Applicable
Completed
Conditions
Colon Cancer
Hypertension
Interventions
Behavioral: MINT
Behavioral: Patient Navigation
First Posted Date
2010-03-24
Last Posted Date
2015-04-22
Lead Sponsor
NYU Langone Health
Target Recruit Count
740
Registration Number
NCT01092078
Locations
🇺🇸

NYU School of Medicine, New York, New York, United States

Irinotecan and Bevacizumab for Recurrent Ovarian Cancer

Phase 2
Completed
Conditions
Ovarian Cancer
Fallopian Tube Cancer
Primary Peritoneal Carcinoma
Interventions
First Posted Date
2010-03-23
Last Posted Date
2015-11-24
Lead Sponsor
NYU Langone Health
Target Recruit Count
29
Registration Number
NCT01091259
Locations
🇺🇸

Bellevue Hospital Center (NYU Langone Medical Center affiliate), New York, New York, United States

🇺🇸

New York University Clinical Cancer Center, New York, New York, United States

Continuous Glucose Monitoring in Type 2 Diabetes Mellitus

Completed
Conditions
Diabetic Vascular Complications
First Posted Date
2010-03-09
Last Posted Date
2019-02-06
Lead Sponsor
NYU Langone Health
Target Recruit Count
28
Registration Number
NCT01083043
Locations
🇺🇸

Winthrop University Hospital, Mineola, New York, United States

Asthma Education Using Child Life Services and an Asthma-based Computer Game

Not Applicable
Completed
Conditions
Asthma
First Posted Date
2010-02-19
Last Posted Date
2020-02-28
Lead Sponsor
NYU Langone Health
Target Recruit Count
27
Registration Number
NCT01072123
Locations
🇺🇸

Winthrop University Hospital, Mineola, New York, United States

Effectiveness and Duration of Effect of Open Treatment in Attention Deficit Hyperactivity Disorder (ADHD) Patients Treated With Lisdexamfetamine Dimesylate(Vyvanse)

Phase 4
Completed
Conditions
Attention Deficit Hyperactivity Disorder
Interventions
Drug: LDX Treatment
First Posted Date
2010-02-18
Last Posted Date
2018-04-03
Lead Sponsor
NYU Langone Health
Target Recruit Count
40
Registration Number
NCT01070394
Locations
🇺🇸

NYU School of Medicine, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath